Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Global Blood Therapeutics, Inc. - Common Stock (NQ:GBT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 4, 2022 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	68.47 (25)
Ask (Size)	68.49 (90)
Prev. Close	68.49
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	67,463,704
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biotech Stocks Well-Positioned For The Fourth Quarter ↗

October 12, 2022

The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.

Via Talk Markets

These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗

September 20, 2022

We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.

Via Talk Markets

Performance

More News

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗

September 15, 2022

Via Investor's Business Daily

Global Blood Therapeutics's Return On Capital Employed Overview ↗

September 15, 2022

Via Benzinga

Where Global Blood Therapeutics Stands With Analysts ↗

August 09, 2022

Via Benzinga

Pfizer Inks $5.4 Billion Deal To Acquire Global Blood Therapeutics ↗

August 08, 2022

Via Investor's Business Daily

Pfizer Scoops Up Sickle Disease Player For $5B ↗

August 08, 2022

Via Benzinga

Global Blood Therapeutics's Return On Capital Employed Overview ↗

September 01, 2022

Via Benzinga

After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal ↗

September 01, 2022

Via Benzinga

GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT

August 31, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗

August 29, 2022

Via Investor's Business Daily

Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million ↗

August 23, 2022

Via Investor's Business Daily

Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review ↗

August 12, 2022

Via Investor's Business Daily

Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US ↗

August 09, 2022

Via Benzinga

8 Analysts Have This to Say About Global Blood Therapeutics ↗

August 09, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022 ↗

August 09, 2022

Via Benzinga

Global Blood Therapeutics: Q2 Earnings Insights ↗

August 08, 2022

Via Benzinga

August 08, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Why These Pfizer Analysts Like The Global Blood Therapeutics Deal ↗

August 08, 2022

Via Benzinga

TBLT, RDBX: The Top 5 Short Squeeze Stocks to Watch This Week ↗

August 08, 2022

Via InvestorPlace

GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics ↗

August 08, 2022

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 ↗

August 08, 2022

Via Benzinga

Global Blood (GBT) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Global Blood Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GBT

August 08, 2022

From Halper Sadeh LLP

Via Business Wire

Benzinga Before The Bell: Elon Musk Confirms Tesla AI Day Part 2, Dogecoin Scam, BioNTech Q2 Earnings Shocker And Other Top Financial Stories Monday, August 8 ↗

August 08, 2022

Via Benzinga

iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗

August 08, 2022

Via Benzinga

Frequently Asked Questions

Is Global Blood Therapeutics, Inc. - Common Stock publicly traded?

Yes, Global Blood Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Global Blood Therapeutics, Inc. - Common Stock trade on?

Global Blood Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Global Blood Therapeutics, Inc. - Common Stock?

The ticker symbol for Global Blood Therapeutics, Inc. - Common Stock is GBT on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.